CClinicalTrials.gg
Active, not recruitingNCT06150846Updated Jul 23, 2024

Sperm Video Recording Protocol

An observational study in Sperm Classification, sponsored by BAIBYS Fertility. Active, not recruiting at 1 site in United States. Open to male participants aged 22 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-23.

Sponsored by BAIBYS Fertility · Observational

From the registry’s dates

  • Primary completion was expected by Aug 2024, 2 years 2 months ago, but the record still lists the study as active, not recruiting.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
40
Ages
22 Years and older
Sex
Male
01

Study summary

The purpose of this study is to obtain anonymous video clips of male semen at high magnification, to manually select out of the video spermatozoon images, and to manually classify their morphology by qualified embryologists based on the WHO Manual criteria in order to train the BAIBYS™ Fertility System. The study will enroll males attending the clinic who may elect to contribute their unused excess sample materials from semen analysis or IVF/ICSI (Intracytoplasmic sperm injection) which is a technique used during in vitro fertilization (IVF).

Read the detailed description

The study will obtain video clips of 40 male subjects semen sample at high magnification. Each subject contributes 1 sample from which 10 minutes of video is recorded.

A total of 720,000 frames are expected to be collected at 30 frames per second. At least 6,000 frames will be selected at random from these 10,800-14,500 frames to be labeled by at least two embryologists. The sperm morphology will be rated according to the Kruger criteria per the WHO 6th edition. The data collected will be utilized to train the Artificial Intelligence (AI) used within the BAIBYS System.

02

Conditions studied

  • Sperm Classification

Keywords

  • Sperm
  • Artificial Inteligence
03

In context

Lead sponsor

BAIBYS Fertility is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years and older
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study will enroll 30-40 male subjects attending the clinic and willing to contribute their unused excess sample materials from semen analysis or IVF/ICSI. Enrollment will include three sub-populations of at least 15 patients to ensure diversity [characteristics of ethnic and racial diversity, BMI diversity, and normal (> WHO 5%ile cutoffs) versus abnormal morphology].

Inclusion criteria

  • Assigned male at birth and possessing typical male anatomy (i.e., one or two testicles and penis)
  • Scheduled to produce a semen sample for fertility evaluation
  • Able to produce a semen sample, including, in the judgement of the PI, ability to follow instructions provided in English by the physician or physician's team members
  • At least a 10th grade education level, to be able to read and understand the ICF; evaluated by either completion of 10th grade, or by any higher level of education or GED
  • Age 22 or older at the time of consent

Exclusion criteria

Exclusion Criteria:

  • Known azoospermia prior to semen analysis.
  • Subjects with azoospermia or otherwise inadequate sample discovered during the trial will be compensated for their participation in recognition of their efforts to contribute to science, but will be replaced with an additional subject for the data collection and labeling to reach a total sample of up to 40 videos
  • History of chemotherapy or radiation within prior 12 months, due to increased chance of azoospermia
  • Developmental delays or other neurological impairment that could impair ability to freely consent, as evaluated by the PI
  • Any reason why in the sole judgement of the PI, consent to participate cannot be freely given
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
40 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Obtaining 6,000 classified sperm images

    Obtaining 6,000 sperm images classified each by at least 2 embryologist based on the WHO 6th edition criteria to add to the AI training of the Baibys system.

    Time frame: Each semen sample will be recorded for 10 minutes

07

Study locations

1 site
  • CCRM Northern Virginia
    Vienna, Virginia 22182, United States
08

References and documents

Individual participant data

Plan to share: Yes — Anonymized patient's data including selection of sperm images/videos will be used together with the clinical study report and protocol will be shared to the medical writer and the supervisor author for the purpose of the the final publication.

Supporting information: Study protocol, Csr

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06150846
Lead sponsor
BAIBYS Fertility
Responsible party
Sponsor
First posted
Nov 29, 2023
Start date
Dec 1, 2023
Primary completion
Aug 1, 2024 (estimated)
Completion
Aug 1, 2024 (estimated)
Last update
Jul 23, 2024

Study contacts

Carter Owen, M.D.
principal investigator · CCRM Fertility Clinic and IVF Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion